These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 31066254)
21. Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis. Hua-Huy T; Le-Dong NN; Duong-Quy S; Bei Y; Rivière S; Tiev KP; Nicco C; Chéreau C; Batteux F; Dinh-Xuan AT J Breath Res; 2015 Jun; 9(3):036007. PubMed ID: 26079155 [TBL] [Abstract][Full Text] [Related]
22. Animal model of sclerotic skin. III: Histopathological comparison of bleomycin-induced scleroderma in various mice strains. Yamamoto T; Kuroda M; Nishioka K Arch Dermatol Res; 2000 Nov; 292(11):535-41. PubMed ID: 11194891 [TBL] [Abstract][Full Text] [Related]
23. Gelatinase expression and proteolytic activity in giant-cell arteritis. Segarra M; García-Martínez A; Sánchez M; Hernández-Rodríguez J; Lozano E; Grau JM; Cid MC Ann Rheum Dis; 2007 Nov; 66(11):1429-35. PubMed ID: 17502363 [TBL] [Abstract][Full Text] [Related]
24. Amelioration of bleomycin-induced pulmonary fibrosis in a mouse model by a combination therapy of bosentan and imatinib. Chilakapati SR; Serasanambati M; Vissavajjhala P; Kanala JR; Chilakapati DR Exp Lung Res; 2015 May; 41(4):173-88. PubMed ID: 25844688 [TBL] [Abstract][Full Text] [Related]
25. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis. Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K Front Immunol; 2019; 10():1861. PubMed ID: 31481954 [TBL] [Abstract][Full Text] [Related]
26. Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis. Oggionni T; Morbini P; Inghilleri S; Palladini G; Tozzi R; Vitulo P; Fenoglio C; Perlini S; Pozzi E Eur J Histochem; 2006; 50(4):317-25. PubMed ID: 17213041 [TBL] [Abstract][Full Text] [Related]
27. Animal model of sclerotic skin. I: Local injections of bleomycin induce sclerotic skin mimicking scleroderma. Yamamoto T; Takagawa S; Katayama I; Yamazaki K; Hamazaki Y; Shinkai H; Nishioka K J Invest Dermatol; 1999 Apr; 112(4):456-62. PubMed ID: 10201529 [TBL] [Abstract][Full Text] [Related]
28. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis. Swiderski RE; Dencoff JE; Floerchinger CS; Shapiro SD; Hunninghake GW Am J Pathol; 1998 Mar; 152(3):821-8. PubMed ID: 9502424 [TBL] [Abstract][Full Text] [Related]
29. In vivo investigations on anti-fibrotic potential of proteasome inhibition in lung and skin fibrosis. Fineschi S; Bongiovanni M; Donati Y; Djaafar S; Naso F; Goffin L; Argiroffo CB; Pache JC; Dayer JM; Ferrari-Lacraz S; Chizzolini C Am J Respir Cell Mol Biol; 2008 Oct; 39(4):458-65. PubMed ID: 18458239 [TBL] [Abstract][Full Text] [Related]
30. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases. Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759 [TBL] [Abstract][Full Text] [Related]
31. Transcriptome analysis reveals key genes modulated by ALK5 inhibition in a bleomycin model of systemic sclerosis. Decato BE; Ammar R; Reinke-Breen L; Thompson JR; Azzara AV Rheumatology (Oxford); 2022 Apr; 61(4):1717-1727. PubMed ID: 34289031 [TBL] [Abstract][Full Text] [Related]
32. 2-Methoxyestradiol inhibits bleomycin-induced systemic sclerosis through suppression of fibroblast activation. Zhu L; Song Y; Li M J Dermatol Sci; 2015 Jan; 77(1):63-70. PubMed ID: 25465161 [TBL] [Abstract][Full Text] [Related]
33. Antifibrogenic effects of C-C chemokine receptor type 2 antagonist in a bleomycin-induced scleroderma model. Ishikawa M; Yamamoto T Exp Dermatol; 2021 Jan; 30(1):179-184. PubMed ID: 32096250 [TBL] [Abstract][Full Text] [Related]
34. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases. Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737 [TBL] [Abstract][Full Text] [Related]
35. TIMP-1 is a key factor of fibrogenic response to bleomycin in mouse lung. Manoury B; Caulet-Maugendre S; Guénon I; Lagente V; Boichot E Int J Immunopathol Pharmacol; 2006; 19(3):471-87. PubMed ID: 17026855 [TBL] [Abstract][Full Text] [Related]
36. Netrin-1 Regulates Fibrocyte Accumulation in the Decellularized Fibrotic Sclerodermatous Lung Microenvironment and in Bleomycin-Induced Pulmonary Fibrosis. Sun H; Zhu Y; Pan H; Chen X; Balestrini JL; Lam TT; Kanyo JE; Eichmann A; Gulati M; Fares WH; Bai H; Feghali-Bostwick CA; Gan Y; Peng X; Moore MW; White ES; Sava P; Gonzalez AL; Cheng Y; Niklason LE; Herzog EL Arthritis Rheumatol; 2016 May; 68(5):1251-61. PubMed ID: 26749424 [TBL] [Abstract][Full Text] [Related]
38. Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma. Park GT; Yoon JW; Yoo SB; Song YC; Song P; Kim HK; Han J; Bae SJ; Ha KT; Mishchenko NP; Fedoreyev SA; Stonik VA; Kim MB; Kim JH Mar Drugs; 2021 Apr; 19(5):. PubMed ID: 33922418 [TBL] [Abstract][Full Text] [Related]
39. EHP-101, an oral formulation of the cannabidiol aminoquinone VCE-004.8, alleviates bleomycin-induced skin and lung fibrosis. García-Martín A; Garrido-Rodríguez M; Navarrete C; Del Río C; Bellido ML; Appendino G; Calzado MA; Muñoz E Biochem Pharmacol; 2018 Nov; 157():304-313. PubMed ID: 30076848 [TBL] [Abstract][Full Text] [Related]
40. Wnt antagonist DKK-1 levels in systemic sclerosis are lower in skin but not in blood and are regulated by microRNA33a-3p. Henderson J; Pryzborski S; Stratton R; O'Reilly S Exp Dermatol; 2021 Jan; 30(1):162-168. PubMed ID: 32592422 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]